This 2020 electron microscope image provided by the National Institute of Allergy and Infectious Diseases - Rocky Mountain Laboratories shows SARS-CoV-2 virus particles which cause COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in a lab. According to a study released in The Lancet Global Health on Wednesday, Oct. 27, 2021, Fluvoxamine, a cheap antidepressant, reduced the need for hospitalization among high-risk adults with COVID-19. (NIAID-RML via AP)
By Carla K. Johnson
A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.
Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.
They've shared the results with the U.S. National Institutes of Health, which publishes treatment guidelines, and they hope for a World Health Organization recommendation.
“If WHO recommends this, you will see it widely taken up,” said study co-author Dr. Edward Mills of McMaster University in Hamilton, Ontario, adding that many poor nations have the drug readily available. “We hope it will lead to a lot of lives saved.”
The pill, called fluvoxamine, would cost $4 for a course of COVID-19 treatment. By comparison, antibody IV treatments cost about $2,000 and Merck's experimental antiviral pill for COVID-19 is about $700 per course. Some experts predict various treatments eventually will be used in combination to fight the coronavirus.
Researchers tested the antidepressant in nearly 1,500 Brazilians recently infected with coronavirus who were at risk of severe illness because of other health problems, such as diabetes. About half took the antidepressant at home for 10 days, the rest got dummy pills. They were tracked for four weeks to see who landed in the hospital or spent extended time in an emergency room when hospitals were full.
In the group that took the drug, 11% needed hospitalization or an extended ER stay, compared to 16% of those on dummy pills.
The results, published Wednesday in the journal Lancet Global Health, were so strong that independent experts monitoring the study recommended stopping it early because the results were clear.
Questions remain about the best dosing, whether lower risk patients might also benefit and whether the pill should be combined with other treatments.
The larger project looked at eight existing drugs to see if they could work against the pandemic virus. The project is still testing a hepatitis drug, but all the others — including metformin, hydroxychloroquine and ivermectin — haven't panned out.
The cheap generic and Merck's COVID-19 pill work in different ways and “may be complementary,” said Dr. Paul Sax of Brigham and Women’s Hospital and Harvard Medical School, who was not involved in the study. Earlier this month, Merck asked regulators in the U.S. and Europe to authorize its antiviral pill.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
Andrew Chanin, CEO of investment management firm ProcureAM, joined Cheddar to break down the many industries in the space economy and discuss what trends are driving the most growth. "Right now there's been so much media focus on space tourism. Why? Because last year it really debuted itself to the world," he said. "However it's less than 1 percent of the overall space economy, and there are many other parts of space which are actually driving this area."
Plastic has become the face of global pollution. To date, humans have produced 8.3 billion metric tons of it. Once discarded, plastic doesn’t biodegrade. Instead, it fragments into microplastics smaller than the size of a sesame seed and further into nanoplastics.
These tiny particles of plastic end up everywhere, deep in the ice of Antarctic glaciers or even inside our bodies.
So how much plastic is inside of us? And what does it mean for our health? Let’s find out.
Catching you up on what you Need to Know on Mar 29, 2022, with updates on the snow squall in Pennsylvania that caused a pileup killing three, the teacher's strike in Sacramento heading into week two, Walmart no longer selling tobacco products in select stores, and what meme stocks are up to this week.
Catching you up on what you Need to Know on Mar 28, 2022, with peace talks resuming in Ukraine as early as today, Colorado wildfires causing evacuations, Shanghai, China, ramping up restrictions once again, the Oscars debacle between Will Smith and Chris Rock, and more.
The U.S. market value of the plant-based food industry reached an all-time high last year. According to a new report from the Plant Based Food Association, retail sales of plant-based foods reached $7.4 billion, but questions are arising over whether the industry can sustain the levels of growth it had in the past few years. Julie Emmett, senior director of marketplace development at the Plant Based Food Association, joined Cheddar News' Closing Bell to discuss.
Bowery Farming's vertical growing process allows it to cultivate 13 types of greens — and now, strawberries — in a sustainable way that's also faster than traditional farming. Bowery focuses on sustainability from start to finish, using unique technology to provide plants with what they need at the right time while eliminating waste and cutting down on carbon dioxide emissions. Katie Seawell, Chief Commercial Officer of Bowery Farming, joins Closing Bell to discuss the company's vertical farming process, sustainability focus, fixing the food supply chain, and more.
Nexii, a company based in Canada, is getting some big backing for its sustainable, low-carbon concrete alternative. CEO Stephen Sidwell, joined Cheddar News to talk about the initiatives his company is taking to tackle climate change and scaling up production to meet demand. "Most people don’t realize it, but buildings are the number one contributor to CO2 emissions," he said. "So that's really what we're attacking, the overall CO2 emissions."
Catching you up on what you need to know on March 25, 2022, with Ukrainian forces retaking Kyiv, 300 deaths reported from the bombing of a theater used as a shelter in Mariupol, U.S. regulators ditch a climate review of natural gas projects, the 94th Academy Awards, and more.
New York City Mayor Eric Adams has announced the removal of the mask mandate in school and day-care centers for children under 5. If COVID-19 cases remain low, this change will take place on April 4th. Syra Madad, an infectious disease epidemiologist, joins Cheddar News to discuss.
